TRN-000632

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTRN-000632
Drug Alias NameTRN-000632
ClassificationSmall molecules
Mechanisms of ActionBcr-Abl tyrosine kinase inhibitors
TargetsBcr-Abl tyrosine kinase
Therapy Area/IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesShanghai Terns Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Hansoh Pharmaceutical Group Co LtdShanghai Terns Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Lymphocytic, Chronic, B-Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A